logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hima Medical (03309.HK) spent HK$312,200 on May 8 to repurchase 182,000 shares.

date
09/05/2025
Zhtng Cijng APP News, Heimai Medical (03309.HK) announced that on May 8, 2025, they spent HK$312,200 to repurchase 182,000 shares, at a repurchase price of HK$1.71-1.72 per share.
Latest
2 m ago
The yield on 2 to 5 year US treasury bonds increased by 10 basis points on the same day.
3 m ago
Euro against Pound Sterling (EUR/GBP) fell by 0.50% intraday, now at 0.8459.
3 m ago
Citi: Maintaining a neutral rating on Skyworks Solutions (SWKS.US), adjusting target price from $70.00 to $66.00.
4 m ago
Spot gold has just fallen below the $3310.00 per ounce level, with the latest price at $3309.78 per ounce, down 1.62% intraday; COMEX gold futures are currently trading at $3315.00 per ounce, down 2.27% intraday.
4 m ago
Piper Sandler: Maintains the rating of AppLovin (APP.US) at Neutral, adjusting it from Neutral to Outperform, with a target price adjusted from $425.00 to $455.00.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.